AVISE ANALYTICS REINITIATES COVERAGE ON BIOXYTRAN INC.
Avise Analytics, a leading equity research firm specializing in micro-cap and small-cap public companies’ research, has reinitiated coverage on Bioxytran, Inc. (OTCQB: BIXT), a clinical stage biotechnology company developing novel therapies targeting the treatment of significant unmet medical needs in virology, degenerative disease, and hypoxia. The in-depth...
